Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that in patients with type 2 diabetes,
the addition of exenatide will result in lower time-averaged serum glucose during a 24-hour
period, compared with placebo.